Sanquin Blood Supply Foundation:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sanquin Blood Supply Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9828
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sanquin Blood Supply Foundation (Sanquin) is a provider of blood bank and diagnostic services, plasma derived products, tissues and cells and reagents. It offers blood-related lab tests for hospitals, blood banks, obstetricians practices, pharmaceutical companies, insurance organizations, and various other institutes. The organization’s plasma derived products cater to various immunology disorders, and blood clotting disorders. Sanquin also conducts research to discover and develop new solutions for medical problems in the areas of transfusion medicine, hematology and immunology. It conducts research in collaboration with academic and research centers in the Netherlands and other countries. The organization has subsidiaries in Finland, Belgium, and the Netherlands. Sanquin is headquartered in Amsterdam, the Netherlands.

Sanquin Blood Supply Foundation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sanquin Blood Supply Foundation, Medical Devices Deals, 2012 to YTD 2018 9
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Xenikos Raises USD30 Million in Series B Financing 11
Xenikos Raises Funds in Venture Financing 12
Xenikos Raises US$7 Million In Series A Financing 13
Partnerships 15
Sanquin Blood Supply Enters Into Partnership with Okklo Life Sciences 15
Licensing Agreements 16
Synthon Biopharma Enters into Licensing Agreement with Sanquin Blood Supply Foundation 16
Immatics Biotech Enters into Licensing Agreement with Sanquin Blood Supply Foundation 17
Neon Therapeutics Enters into Licensing Agreement with Sanquin Blood Supply Foundation 18
Sanquin Blood Supply Foundation – Key Employees 19
Sanquin Blood Supply Foundation – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanquin Blood Supply Foundation, Deals By Therapy Area, 2012 to YTD 2018 8
Sanquin Blood Supply Foundation, Medical Devices Deals, 2012 to YTD 2018 9
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Xenikos Raises USD30 Million in Series B Financing 11
Xenikos Raises Funds in Venture Financing 12
Xenikos Raises US$7 Million In Series A Financing 13
Sanquin Blood Supply Enters Into Partnership with Okklo Life Sciences 15
Synthon Biopharma Enters into Licensing Agreement with Sanquin Blood Supply Foundation 16
Immatics Biotech Enters into Licensing Agreement with Sanquin Blood Supply Foundation 17
Neon Therapeutics Enters into Licensing Agreement with Sanquin Blood Supply Foundation 18
Sanquin Blood Supply Foundation, Key Employees 19
Sanquin Blood Supply Foundation, Subsidiaries 20

List of Figures
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sanquin Blood Supply Foundation, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Sanquin Blood Supply Foundation:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Toyo Kanetsu K.K.:企業の戦略・SWOT・財務情報
    Toyo Kanetsu K.K. - Strategy, SWOT and Corporate Finance Report Summary Toyo Kanetsu K.K. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • ARMO Biosciences Inc (ARMO):製薬・医療:M&Aディール及び事業提携情報
    Summary ARMO Biosciences Inc (ARMO Biosciences) is an immuno-oncology company that develops tumors treatment drugs. Its pipeline drug candidates include AM0010, AM0015, AM0012, AM0003 and AM0001. ARMO Biosciences’s lead immunotherapy AM0010 is along-acting form of recombinant human Interleukin 10 (I …
  • HumanOptics AG (H9O1):企業の財務・戦略的SWOT分析
    Summary HumanOptics AG (HumanOptics), a subsidiary of Medipart AG, is a medical device company that develops, manufactures and distributes intraocular implants for opthalmic surgeries. The company offers products such as intraocular lenses, artificiallris, capsular tension rings and cornea implants. …
  • Bharti Airtel Limited:企業の戦略・SWOT・財務分析
    Bharti Airtel Limited - Strategy, SWOT and Corporate Finance Report Summary Bharti Airtel Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • LendingClub Corporation (LC):企業の財務・戦略的SWOT分析
    LendingClub Corporation (LC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Ambuja Cements Limited:企業の戦略・SWOT・財務分析
    Ambuja Cements Limited - Strategy, SWOT and Corporate Finance Report Summary Ambuja Cements Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Dr. Reddy’s Laboratories Limited:企業の戦略・SWOT・財務情報
    Dr. Reddy's Laboratories Limited - Strategy, SWOT and Corporate Finance Report Summary Dr. Reddy's Laboratories Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Taisho Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Taisho Pharmaceutical Co Ltd (Taisho), a subsidiary of Taisho Pharmaceutical Holdings Co Ltd is a pharmaceutical company that develops, manufactures and markets a range of prescription pharmaceutical and self-medication drugs. The company offers products that include lipovitan D, riup, clari …
  • Coloplast AS (COLO B):医療機器:M&Aディール及び事業提携情報
    Summary Coloplast A/S (Coloplast) is a medical device company that offers products and services for ostomy care, urology care, continence care, and skin and wound care. Its major products include ostomy bags; urisheaths; urine bags; catheters; anal irrigation systems; vaginal sling products; advance …
  • Slovensky plynarensky priemysel AS:企業の戦略的SWOT分析
    Slovensky plynarensky priemysel AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Berger Paints India Ltd (BERGEPAINT):企業の財務・戦略的SWOT分析
    Berger Paints India Ltd (BERGEPAINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Nitori Holdings Co Ltd:企業の戦略・SWOT・財務情報
    Nitori Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nitori Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Thai Beverage Public Company Limited:戦略・SWOT・企業財務分析
    Thai Beverage Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thai Beverage Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • InKemia IUCT Group SA (IKM):製薬・医療:M&Aディール及び事業提携情報
    Summary InKemia IUCT Group SA (InKemia IUCT), formerly Institut Univ De Ciencia i Technology SA, is a biotechnology company. The company provides research and development, technological, and consulting services. It offers customized research services. InKemia IUCT provides technology services such a …
  • Clarion Co Ltd:企業の戦略的SWOT分析
    Clarion Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Axikin Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Axikin Pharmaceuticals Inc (Axikin) is a biopharmaceutical company that develops small molecule therapeutics for respiratory disorders. The company offers pre-clinical and research programs with small molecule therapeutics for applications in asthma, chronic obstructive pulmonary disease, in …
  • Huntington Memorial Hospital:企業の戦略的SWOT分析
    Huntington Memorial Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • BowLeven plc (BLVN):企業の財務・戦略的SWOT分析
    Summary BowLeven plc (BowLeven) is an independent oil and gas exploration and production company. The company’s business activities include acquisition, exploration, and development of oil and gas properties. BowLeven holds equity interests in offshore and onshore exploration acreage in Cameroon and …
  • Protagen AG-製薬・医療分野:企業M&A・提携分析
    Summary Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment. The company’s products include multilisa Ssc, multilisa SLE and multilisa RA. It provides products for autoimmune diseases such as rheumatoid arthritis, neuromyeliti …
  • Modern India Ltd:企業の戦略・SWOT・財務情報
    Modern India Ltd - Strategy, SWOT and Corporate Finance Report Summary Modern India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆